MUSCLE, GROWTH & RECOVERY
Studied for recovery, sleep, and vitality by prompting the body to release its own growth hormone.
Sermorelin is a research peptide that copies the body's own growth-hormone-releasing hormone. It is one of the most studied and cleanest approaches to stimulating natural growth hormone and IGF-1 release, because it works with the body's natural release rhythm—in pulses—rather than overriding it. It has an extensive clinical history and prior regulatory approval.
Included because it has an extensive clinical research history and prior regulatory approval, works through a well-characterized GHRH-receptor mechanism, and has a long, consistent track record of research use. It anchors the established end of the GH-axis research spectrum.
Binds the pituitary receptor for growth-hormone-releasing hormone and stimulates the body's own release, in the pulses described as mimicking a younger pattern.
Described as producing no shutdown of natural production, no spike in cortisol or prolactin, and no loss of response when cycled appropriately.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
Sermorelin was previously FDA-approved and later withdrawn from the U.S. market for commercial (not safety) reasons. Material offered here is sold and offered strictly for laboratory and research use.
